Acropolis Investment Management »

Regeneron Pharmaceuticals shares owned by Acropolis Investment Management

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Acropolis Investment Management from 13F filings

Historical chart of Acropolis Investment Management investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Acropolis Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Acropolis Investment Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $107k 102 1051.24
2024-06-30 $107k 102 1051.03

More positions owned by Acropolis Investment Management

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Bd Index Total Bnd Mrkt (BND)
Vanguard Tax-managed Ftse Dev Mkt Etf (VEA)
Ishares Tr Core S&p Scp Etf (IJR)
Ishares Tr Core S&p Mcp Etf (IJH)
Ishares Tr Intrm Tr Crp Etf (IGIB)
Vanguard Scottsdale Fds Short Term Treas (VGSH)
Vanguard Scottsdale Fds Mortg-back Sec (VMBS)
Ishares Tr Us Sml Cap Eqt (SMLF)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Vanguard Index Fds Large Cap Etf (VV)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr Msci Usa Mmentm (MTUM)
Msci Intl Moment Ishares Tr (IMTM)
Dimensional Etf Trust Us Large Cap Val (DFLV)

View all positions for Acropolis Investment Management

Top funds holding Regeneron Pharmaceuticals

Vanguard Group
BlackRock
BlackRock
Jpmorgan Chase & Co
State Street Corporation
Capital World Investors
Capital Research and Management Company - Division 3
Dodge & Cox
Geode Capital Management
Franklin Resources
Morgan Stanley
T. Rowe Price Associates
Invesco
Bank of America Corporation
Amundi

View all funds holding Regeneron Pharmaceuticals